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ferent European and Latin American countries has been deter- 
mined in surveys carried out between 1989 and 1997. In some 
countries - Germany, UK, Italy, Spain, Denmark and Finland - 
aminoglycoside resistance in Enterobacteriaceae is predominantly 
caused by gentamicin-modtfymg enzymes (AAC(3)-1, AAC(S)-II, 
and/or ANT(2”)-I). However, in other countries - Belgium, 
France, Greece, Portugal, Turkey, South Africa, Argentina, Chile 
and Mexico - aminoglycoside resistance is most often caused by an 
amikacin-modifymg enzyme (AAC(6‘)-I) either alone or in combi- 
nation with the above-mentioned gentamicin-mo-g enzymes. 
A correlation between the types of enzymes observed and amino- 
glycoside usage in these countries has been suggested and will be 
discussed. 
In the treatment of mfections caused by resistant organism, a 
kequent problem in many intensive care units, the most ke ly  
mechanism of resistance to aminoglycosides should play a role in 
the empiric choice of antibiotics. In those hospitals where gentam- 
icin-modifymg enzymes predominate, n e h c i n  and amikacin may 
still be effective choices. Where ACC(6’)-I occurs alone, gentamicin 
may s t i l l  be useful. However, in countries where combinations of 
resistance mechanism occur, only isepamicin retains good in vitro 
activity and should be considered as a first choice in situations where 
aminoglycoside resistance is high. 
How do pharmacokinetics influence the choice of 
aminoglycoside in the critically 111 patient? 
E Scaghone. Department of Phamacology, University of Milan, Milan, 
Italy 
Aminoglycosides remain a mainstay of treatment for serious 
Gram-negative mfections. 
Following intramuscular administration, aminoglycosides are 
completely absorbed; they are not metabolized and any drug sub- 
stance in the plasma and urine is unchanged drug. Anminoglycosides 
are completely elmhated via the renal route. Doses should there- 
fore be adjusted in patients with renal insufficiency according to the 
extent of renal impairment. 
The area under the plasma concentration curve (AUC) is propor- 
tional to the dose of aminoglycoside administered while dearance, 
volume of distribution at steady state and half-life are independent of 
dose. After intravenous dosing, the aminoglycoside plasma concen- 
tration curve can be best characterized by a m-exponential curve. 
The first half-life represents the distribution phase, the second repre- 
sents the elimination phase, while the g-phase represents the return 
of the drug to the plasma &om deep compartments (i.e. binding in 
renal tissue). 
Isepamicin is a new aminoglycoside which has activity against 
many bacteria resistant to other aminoglycosides. The pharmacoki- 
netics of isepamicin are uncomplicated and generally s d a r  to those 
of other aminoglycosides, although evidence suggests that it may 
have hgher peak levels and less tissue accumulation. The g-phase 
is 34 hours while that of gentamicin and tobramycin is 94 and 96 
hours, respectively. Decreased tissue accumulation, implied h m  
these pharmacokinetic data, could be clinically relevant in term of 
reduced ototoxicity and renal toxicity, especially in compromised 
patients. 
The Evolution of Dosing Schedules in 
Aminoglycoside Therapy 
P. Tulkens. B 
No abstract available. 
The Rationale for and Use of Aminoglycosides in 
Combination Therapy 
J. Chow. USA 
No abstract available. 
Consensus on the clinical use of aminoglycosides 
-the Swiss Experience 
A.U. Gerber. Med. KZinik. Reg.spifal Biel-Bienne, Switzerland 
Background: Substand (up to five-fold), poorly understood varia- 
tions in the use and consumption of aminoglycosides (agly) has been 
observed among different Swiss hospitals of similar size and patient 
structure. 
Objective: Better understandmg of arguments for and against 
the use of agly for various indications. Swiss consensus for agly 
recommendations. 
Design: Consensus conference including experts h m  all Swiss 
university hospitals and representative county hospitals. 
Topics: Use and consumption of agly; role of agly and optimal 
schedule for various infections in different target patients; practice of 
monitoring. 
Conclusions: Agly are highly recommended (q8h) as part of the 
standard treatment of 1. endocarditis due to streptococci (MIC of 
peniG t 0.1 mg/l) or enterococci; 2. the initial 2-3 days of en- 
docarditis due to staphylococci; 3. the febrile neutropenic patient 
with sepsis; 4. exacerbations of bronchopulmonary infections in 
cystic fibrosis patients.Minor recommendatiom (OD regimen) are for: 
1. shortening the duration of antibiotic combination treatment of 
endocadtis due to streptococcus viridans (MID of peniG < 0.1 
mg/l); 2. combination treatment of the febrile neutropenic patient; 
3. the initial 2-3 days of Gram-negative sepsis (with shock); 3. sep- 
sis/meningitis in the newborn (q8h); 4. some infkquent infections 
such as tularemia, brucellosis, listeria, atypical mycobacteriosis. Mon- 
itoring of mugh lewls is highly recommended. In contrast, monitor- 
ing of peak levels is not needed in OD regimens in particular. 
Bacterial mechanisms for evading cellular 
host defences 
Cell Biology of Phagocytes: Lessons from 
Mycobacteria 
S .  Zimmerli. University Hospital, Zurich, Swi tzerhd  
Mycobacterium tuberculosis survives and replicates within mac- 
rophages but the mechanism whereby tubercle bacdb resist killing 
are incompletely understood. M. tuberculosis enter macrophages by 
receptor-mediated phagocytosis. A remarkable range of Merent 
macrophage receptors mediate phagocytosis and/or bindmg of M. 
tuberculosis: the complement receptors CR1, CR3 and CR4, the 
macrophage mannose receptor, the Fcg receptor, class A scavenger 
receptors, phagocyte CD14 molecules, and the surfactant protein A 
receptor of alveolar macrophages. The survival of certain intracel- 
lular pathogens like S. typhimurium, L. monocytogenes, and L. major 
within macrophages depends on selective use of a receptor that me- 
diates phagocytosis but not &g. In contrast, evidence h m  recep- 
tor blocking experiments suggests that the intracellular survival and 
replication of virulent M. tuberculosis is independent of the receptor 
that mediates phagocytosis. 
By selectively modulating the fusion-capacity of its phagosome 
M. tuberculosis seems to regulate its vacuole’s matuntion along the 
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phagosomal-lysosomal pathway. While r e c y h g  of plasma mem- 
brane proteins and clearance of endosomal markers from the phago- 
some are delayed, only low levels of lysosome-associated mem- 
brane proteins and cathepsin D are found in the vacuole. In ad- 
dition, the vesicular proton-ATPase is excluded from the phago- 
s o d  membrane, impairing full acidification and thus restricting 
the hydrolytic activiry of the vacuole. However, rather than being 
fusion-incompetent vacuoles containing mycobacteria are highly se- 
lective of the intracellular compartments with which the mix. This 
is illustrated by the observation that some plasmalemma-derived 
constituents Wre glycosphingolipids can readily access mycobacte- 
rial vacuoles. Our understanding of the maturation of intracellular 
compartments will be enhanced by further studies on M .  tuberculosis 
containing vacuoles. 
The lmmunopathogenesis of Chlamydia1 Infection 
M.E. Ward. UK 
No abstract available. 
(s491 Molecular and Cellular Mechanisms of Shige//a 
Interaction with Epithelial and Phagocytic Cells: 
An Escape Strategy? 
P.J. Sansonetti. Institut Pasteur, Paris, France 
Invasion of the intestinal barrier by an enteric pathogen such as 
Shigella Jexnm' encompasses a complex interplay of interactions be- 
tween epithelial and phagocytic cells. Massive perturbation of the 
signals that maintain tissue homeostasis and integrity achieves desta- 
bilization of the epithelial cohesion, invasion of epithelial and rnu- 
c o d  cells, and eventually tissue destruction. A major factor in this 
process is expression by S. Jexneti of an "invasive phenotype" related 
to its capacity, upon contact with target cells, to release via a type I11 
secretory apparatus a set of Ipa (invasion) proteins. Ipas can trigger 
entry of the pathogen into epithelial cells via a macropinocyhc event 
that involves massive rearrangement of the cell cytoskeleton. 
Ipas can also trigger macrophage apoptotic death via direct in- 
teraction with the cysteine protease ICE, thus killing defense cells 
and achieving release of IL-lB which initiates inflammation. The 
likely scheme that has emerged from OUT in vitm and in uivo exper- 
iments is the following bacteria translocate through the epithelial 
barrier via M cells of the follicular associated epithelium covering the 
lymph nodes located within the colonic mucosa. Apoptotic death of 
macrophage allows bacterd survival, e n q  into epithelial cells via 
their basal pole, but also triggers early dammation which destabi- 
lizes the epithelial structure and facilitates further bacterial entry. 
Once intracellular, bacteria escape into the cytoplasm and move 
from cell to cell via an actin-dependent process. This overall process 
causes the tissue destruction which is characteristic of shigellosis. 
. 
(s50( Listeria monocytogenes as a Model for Studying 
W Goebel, M. Kuhn, E Engelbrecht, Z. Sokolovic, R. Bockmann. 
Lehrstuhl Mikrobiologie, Biozenttum der Universitiit W i i n b u z ,  A m  
Hublund, 97074 W u n b u z ,  Germany 
Listeria monocytogenes, a Gram-positive, facultative intracellu- 
lar bacterium, can cause systemic infections in pregnant women, 
neonates, and immuno-compromised people with symptoms such as 
septicaemia and encephalo-meningitis. These bacteria enter phago- 
cytes as well as non-phagocytic host cells and replicate in the cytosol 
of these cells after escape h m  the phagosome. In the cytosolic 
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compartment L. monocytogener polymerises actin which allows intra- 
and intercellular movement of the bacteria. All virulent L. m m q -  
togenes strains possess a gene duster flanked by the house keeping 
genes prs (encoding phosphoribosyl-pyrophosphate synthetase) and 
Id (encoding lactate dehydmgenase) which consists of six virulence 
genes. Their products comprise two phospholipases C, listeriolysin, 
a metalloprotease, the actin nucleator ActA and the ~ c r i p t i o n a l  
activator PrfA. This latter regulatory protein is essential for the ex- 
pression of all six clustered virulence genes and the inl genes. The 
inl genes encode leucine-rich repeat (Lrr) proteins that fall into two 
dasses: the large Id proteins are cell-assodated and are involved in 
the internalization of L. monocytogenes into non-professional phago~ 
cytic host cells while the s m a l l  Inls are secretory proteins which are 
synthesised preferentially within the host cells. The Merential ex- 
pression of the virulence genes is accomplished by the interaction 
of PrfA with other bacterial factors which is influenced by environ- 
mental parameters. 
Some of the listerial virulence factors are predominantly expressed 
when the bacteria replicate outside the host cells whereas others are 
m d y  expressed withm the intracellular compartments. Depend- 
ing on the site of synthesis these virulence factors trigger specific 
host cell responses. Host cell responses have been studied in our 
laboratory mainly for the interaction of L. monocytogenes with mac- 
rophages which represent major target cells in L. monocytogenes infec- 
tion. Their reactions are crucial for the progress of a L. monocytogenes 
mfection. 
Tracking methicillin-resistant Staphylococci 
15511 Clonalii and Evolution of Methicillin Resistant 
Staphylococcus Aureus: Application of Molecular 
Typing Techniques for Epidemiologically Valid 
Detection of Genetic Polymorphisms 
A. van Belkum. NL 
No abstract available. 
Tracking and Managing Nosocomial MRSA 
Infections 
J.M. Boyce. Miriam Hospital and Brown University, P r m ' d m ,  RI, 
U S A  
Methi&-resistant S t u p h y l w m  uureus ( M A )  continues to be an 
important nosocomial pathogen. The prevalence of MRSA in hospi- 
tals varies considerably by geographc area, hospital size and possibly 
by hospital type. The percent of S. aureus isolates that are MRSA 
ranges from <5% in some hospitals to more than 60% in others. 
The incidence of ongoing nosocomial transmission of MFSA is best 
expressed as the number of new nosocomial MFSA cases/lOOO pa- 
tient-days. Minimizin g nosocomial transmission of MRSA requires 
prompt detection and reporting of MRSA cases by the laboratory, 
appropriate isolation and barrier precautions, surveillance cultures 
on wards where case clustering occurs, and prompt isolation of 
known cases upon readmission to the hospital. Frequent use of 
gloves by personnel and improved compliance with hand hygiene 
are strategies that deserve increased emphasis. Eradicating MRSA 
nasal carriage in patients and in personnel implicated in transmission 
of MRSA can contribute to control of MRSA, but the indications 
for decolonizadon therapy remain controversial. Currently, intranasal 
mupirocin is the most effective regimen for eradicating nasal carriage. 
Widescale use in hospitals and prolonged application of mupirocin to 
